TAXUS® LIBERTÉ®
Report
- Report Number
- 2134265-2011-02984
- Event Type
- Injury
- Date Received
- July 13, 2011
- Date of Event
- April 6, 2011
- Report Date
- June 13, 2011
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(6). DEVICE IS A COMBINATION PRODUCT. IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
EVENT DATE CORRECTED FROM (B)(6) 2011 TO (B)(6) 2011. (B)(4).
(B)(4).
(B)(4) CLINICAL STUDY. SAME CASE AS 2134265-2011-02983. IT WAS REPORTED THAT FOLLOWING A CORONARY ARTERY STENTING TREATMENT PROCEDURE THE PATIENT EXPERIENCED ANGINA. THE TARGET LESION WAS LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY WITH 75% STENOSIS AND WAS 20 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.5 MM. THE PHYSICIAN TREATED THE LESION BY IMPLANTING TWO TAXUS LIBERTE (3.5 X 28 MM AND 4.0 X 8 MM) STENTS IN AN OVERLAPPING FASHION. FOLLOWING POST DILATATION RESIDUAL STENOSIS WAS 0%. THE PATIENT WAS DISCHARGED THE NEXT DAY ON ASPIRIN AND PRASUGREL. AT 294 DAYS POST INDEX PROCEDURE THE PATIENT EXPERIENCED ANGINA AND WAS HOSPITALIZED. PATIENT UNDERWENT PCI WHICH REVEALED A 50% STENOSIS WITH TIMI 3 FLOW IN THE MID RCA AND A 60% STENOSIS WITH TIMI 3 FLOW IN THE PROXIMAL RCA. THE PATIENT WAS TREATED WITH BALLOON ANGIOPLASTY AND PLACEMENT OF 2 OVERLAPPING NON BSC DRUG ELUTING STENTS. POST TREATMENT DIAMETER STENOSIS WAS 0% WITH TIMI 3 FLOW. THE SUBJECT WAS DISCHARGED LATER THAT DAY.
IT WAS FURTHER REPORTED THAT IN (B)(6) 2011, THE PATIENT WAS SEEN IN THE OFFICE FOR EVALUATION OF RECURRENT CHEST PAIN SINCE THE INDEX PROCEDURE. CORONARY ANGIOGRAPHY REVEALED DIFFUSE 50-60% IN-STENT RESTENOSIS OF THE PREVIOUSLY DEPLOYED STUDY STENTS IN THE OSTIAL TO MID RCA. THE PROXIMAL AND MID RCA WERE TREATED WITH PLACEMENT OF TWO OVERLAPPING 3.5X28MM AND 4.0X12MM NON-BSC DRUG ELUTING STENTS WITH 0% RESIDUAL STENOSIS. THE EVENT WAS CONSIDERED RESOLVED WITHOUT RESIDUAL EFFECTS. ASPIRIN AND PRASUGREL WERE CONTINUED.
(B)(6). SAME CASE AS 2134265-2011-02983. IT WAS REPORTED THAT FOLLOWING A CORONARY ARTERY STENTING TREATMENT PROCEDURE THE PATIENT EXPERIENCED ANGINA. THE TARGET LESION WAS LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY WITH 75% STENOSIS AND WAS 20 MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.5 MM. THE PHYSICIAN TREATED THE LESION BY IMPLANTING TWO TAXUS LIBERTE (3.5 X 28 MM AND 4.0 X 8 MM) STENTS IN AN OVERLAPPING FASHION. FOLLOWING POST DILATATION RESIDUAL STENOSIS WAS 0%. THE PATIENT WAS DISCHARGED THE NEXT DAY ON ASPIRIN AND PRASUGREL. (B)(6) POST INDEX PROCEDURE THE PATIENT EXPERIENCED ANGINA AND WAS HOSPITALIZED. PATIENT UNDERWENT PCI WHICH REVEALED A 50% STENOSIS WITH TIMI 3 FLOW IN THE MID RCA AND A 60% STENOSIS WITH TIMI 3 FLOW IN THE PROXIMAL RCA. THE PATIENT WAS TREATED WITH BALLOON ANGIOPLASTY AND PLACEMENT OF 2 OVERLAPPING NON BSC DRUG ELUTING STENTS. POST TREATMENT DIAMETER STENOSIS WAS 0% WITH TIMI 3 FLOW. THE SUBJECT WAS DISCHARGED LATER THAT DAY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS® LIBERTÉ® | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - MAPLE GROVE | H749389368400 | 13092796 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 44 YR | Required Intervention | 3.50X28MM TAXUS LIBERTE STENT |